文献速递神经儿科影像MR

儿童多次应用钆喷酸葡胺与钆布醇后齿状核和苍白球T1加权信号强度的比较

Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
PubMed 文献 · Invest Radiol · 2018-01-01

该研究比较儿童多次应用线性对比剂钆喷酸葡胺与大环类对比剂钆布醇后,齿状核和苍白球T1加权信号强度的变化。结果显示,钆喷酸葡胺组齿状核与脑桥、齿状核与小脑中脚、苍白球与丘脑的信号强度比值均显著升高,而钆布醇组无显著变化。作者认为颅内T1高信号的临床影响目前尚不明确,但根据欧洲药品管理局药物警戒与风险评估委员会的决定,应优先使用大环类静脉对比剂,并在儿童和青少年中使用MR对比剂时应谨慎并考虑儿童脑发育。

要点

  • 儿童多次应用线性对比剂钆喷酸葡胺后,齿状核和苍白球T1加权信号强度比值显著升高。
  • 大环类对比剂钆布醇多次应用后,齿状核和苍白球T1加权信号强度比值无显著变化。
  • 儿童中钆喷酸葡胺所致T1信号升高模式与成人已发表结果一致。

核心结论

  • 儿童多次应用线性对比剂钆喷酸葡胺后齿状核和苍白球T1加权信号强度升高,而应用大环类对比剂钆布醇后无此变化,与成人结果一致;颅内T1高信号的临床影响目前尚不明确,但根据欧洲药品管理局药物警戒与风险评估委员会的决定,应优先使用大环类静脉对比剂,儿童和青少年使用MR对比剂时应谨慎并考虑儿童脑发育。

研究设计与样本

  • 经机构审查委员会批准,分析两个相似的儿童患者队列,分别仅接受钆喷酸葡胺或钆布醇至少3次连续增强MRI检查。所有MRI检查均在1.5 T系统上进行,采集平扫T1加权自旋回波序列,并在基线MRI和对比剂给药后进行评估。

关键影像表现/征象

  • 钆喷酸葡胺组应用3次后,齿状核与脑桥信号强度比值平均差值为0.036 ± 0.031(P < 0.001)。
  • 钆喷酸葡胺组应用3次后,齿状核与小脑中脚信号强度比值平均差值为0.034 ± 0.032(P < 0.001)。
  • 钆喷酸葡胺组应用3次后,苍白球与丘脑信号强度比值平均差值为0.025 ± 0.025(P = 0.001)。
  • 钆喷酸葡胺组12例应用超过3次的患者亚组分析中,齿状核与脑桥比值平均差值为0.043 ± 0.032(P = 0.001),齿状核与小脑中脚比值为0.041 ± 0.035(P = 0.002),苍白球与丘脑比值为0.028 ± 0.025(P = 0.003)。
  • 钆布醇组应用3次或超过3次后,均未显示对信号强度比值有显著影响。

临床应用与阅片要点

  • 作者指出,根据欧洲药品管理局药物警戒与风险评估委员会的决定,应优先使用大环类静脉对比剂。
  • 作者指出,儿童和青少年使用MR对比剂时应谨慎并考虑儿童脑发育。
  • 作者指出,颅内T1高信号的临床影响目前尚不明确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate and compare changes in T1-weighted signal intensity (SI) within the dentate nucleus (DN) and globus pallidus (GP) in a pediatric population after serial applications of the linear gadolinium-based magnetic resonance contrast medium gadopentetate dimeglumine and the more stable macrocyclic agent gadobutrol.

MATERIALS AND METHODS: Institutional review board approval was obtained. Two similar pediatric patient cohorts who underwent at least 3 serial contrast-enhanced magnetic resonance imaging (MRI) examinations with sole application of gadopentetate dimeglumine or gadobutrol were analyzed. All MRI examinations were performed on a 1.5 T system acquiring unenhanced T1-weighted spin echo sequences, which were evaluated on the baseline MRI and after the contrast medium administrations. For analysis of SI changes in the DN, the ratios of the DN to the pons (P) and to the middle cerebellar peduncle (MCP) were assessed. The GP was compared with the thalamus (TH) by dividing the SIs between GP and TH (GP-to-TH ratio).

RESULTS: Twenty-eight patients (13 boys, 15 girls; mean age, 8.4 ± 6.8 years) who received at least 3 applications of gadopentetate dimeglumine and 25 patients (13 boys, 12 girls; mean age, 9.7 ± 5.4 years) with 3 or more gadobutrol injections were included. After 3 administrations of gadopentetate dimeglumine, the T1-weighted SI ratios significantly increased: mean difference value of 0.036 ± 0.031 (DN-to-P; P < 0.001), 0.034 ± 0.032 (DN-to-MCP; P < 0.001), and 0.025 ± 0.025 (GP-to-TH; P = 0.001). In a subanalysis of 12 patients with more than 3 injections of gadopentetate dimeglumine, the mean differences of the SI ratios were slightly higher: 0.043 ± 0.032 (DN-to-P; P = 0.001), 0.041 ± 0.035 (DN-to-MCP; P = 0.002), and 0.028 ± 0.025 (GP-to-TH; P = 0.003). In contrast, gadobutrol did not show a significant influence on the SI ratios, neither after 3 nor after more than 3 applications.

CONCLUSIONS: The T1-weighted SI increase within the DN and GP after serial administrations of the linear contrast medium gadopentetate dimeglumine, but not after serial applications of the macrocyclic agent gadobutrol, found in a pediatric population, is consistent with results published for adult patients. The clinical impact of the intracranial T1-hyperintensities is currently unclear. However, in accordance with the recent decision of the Pharmacovigilance and Risk Assessment Committee of the European Medicines Agency, intravenous macrocyclic agents should be preferred and MR contrast media should be used with caution and awareness of the pediatric brain development in children and adolescents.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Renz DM, Kümpel S, Böttcher J, et al. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population. Invest Radiol. 2018. PMID: 28976476. doi:10.1097/RLI.0000000000000419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。